Matches in Wikidata for { <http://www.wikidata.org/entity/Q65386065> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q65386065 description "clinical trial" @default.
- Q65386065 description "ensayu clínicu" @default.
- Q65386065 description "klinisch onderzoek" @default.
- Q65386065 description "клінічне випробування" @default.
- Q65386065 name "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 name "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 type Item @default.
- Q65386065 label "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 label "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 prefLabel "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 prefLabel "Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder" @default.
- Q65386065 P1132 Q65386065-71EC8677-0E0C-4D74-BBDC-E9A27E168F84 @default.
- Q65386065 P1476 Q65386065-43476AF2-9A73-4DCC-AD12-E497E36A91BA @default.
- Q65386065 P17 Q65386065-1938EAB8-66AD-4E4F-8269-831580921FE3 @default.
- Q65386065 P17 Q65386065-2EA5877E-C8E7-4CC4-A23E-A8B11DE0FBD1 @default.
- Q65386065 P17 Q65386065-4CE7CDC3-22B2-43DF-9A03-BFD6DC6ABD01 @default.
- Q65386065 P17 Q65386065-4FD87F15-E71C-4F96-85E4-BF7C565734C5 @default.
- Q65386065 P17 Q65386065-61116DF1-E660-45B5-A5C5-A2578FA77A42 @default.
- Q65386065 P17 Q65386065-70ABCF00-F01E-4B98-8476-D0D84F92D514 @default.
- Q65386065 P17 Q65386065-DFA92D99-0955-4601-A674-881DCFCD46A6 @default.
- Q65386065 P17 Q65386065-F05F2961-2F57-4EB3-8FA4-3D76CD426003 @default.
- Q65386065 P1813 Q65386065-08D9D00B-DA41-4F06-904A-22FC7878ACB2 @default.
- Q65386065 P2899 Q65386065-0B5A37EB-9344-43D0-B252-05324577F3FD @default.
- Q65386065 P3098 Q65386065-C8462F5D-4AC4-4459-9847-2FA156591468 @default.
- Q65386065 P31 Q65386065-772E69C1-3AF9-43B4-992D-9497FE77D313 @default.
- Q65386065 P4844 Q65386065-21B7D002-4AE3-4642-B498-BE0C30AB3529 @default.
- Q65386065 P580 Q65386065-BD1312EC-559D-4BA9-A4AF-8F16B89DBD18 @default.
- Q65386065 P582 Q65386065-8DCFFD84-2B7E-4B75-9C99-3299C6E945F5 @default.
- Q65386065 P6099 Q65386065-BEF92594-D322-4548-9113-C6E197FD084E @default.
- Q65386065 P6153 Q65386065-4D353A97-E1F4-4BDA-A921-73261F1A32D4 @default.
- Q65386065 P8363 Q65386065-67ED3487-5B29-4923-B834-1BCBDA733E3C @default.
- Q65386065 P1132 "+257" @default.
- Q65386065 P1476 "A Double-Blind Randomized Withdrawal Study Evaluating the Efficacy and Safety of SR58611A Versus Placebo in the Prevention of Relapse of Anxiety up to 1 Year in Patients With GAD Improved After 12 Weeks of Open Label Treatment With SR58611A." @default.
- Q65386065 P17 Q142 @default.
- Q65386065 P17 Q183 @default.
- Q65386065 P17 Q28 @default.
- Q65386065 P17 Q29 @default.
- Q65386065 P17 Q298 @default.
- Q65386065 P17 Q38 @default.
- Q65386065 P17 Q408 @default.
- Q65386065 P17 Q96 @default.
- Q65386065 P1813 "VEGA" @default.
- Q65386065 P2899 "+18" @default.
- Q65386065 P3098 "NCT00397098" @default.
- Q65386065 P31 Q30612 @default.
- Q65386065 P4844 Q4746121 @default.
- Q65386065 P580 "2006-11-01T00:00:00Z" @default.
- Q65386065 P582 "2007-09-01T00:00:00Z" @default.
- Q65386065 P6099 Q42824827 @default.
- Q65386065 P6153 Q158205 @default.
- Q65386065 P8363 Q78089383 @default.